Livingstone Health Holdings Limited Completes Strategic Acquisition of Wellington Pte. Ltd.

Key Highlights for Investors

• Completion Date: The acquisition was finalized on 4 March 2026.
• Transaction Parties: Phoenix Medical Group Pte. Ltd. (“PMG”), a subsidiary of Livingstone Health Holdings Limited, has acquired the entire issued and paid-up share capital of Wellington Pte. Ltd.
• Resulting Structure: Following completion, Wellington Pte. Ltd. becomes an indirect subsidiary of Livingstone Health Holdings Limited, with PMG now the legal and beneficial owner of all issued shares in Wellington.
• All Conditions Precedent Fulfilled: All required conditions under the Sale and Purchase Agreement (SPA) have been fulfilled and/or waived, confirming the transaction’s compliance and readiness.

Details of the Acquisition

Livingstone Health Holdings Limited (the “Company”) has announced the successful completion of its proposed acquisition of Wellington Pte. Ltd. This move was executed through its wholly-owned subsidiary, Phoenix Medical Group Pte. Ltd. (“PMG”). The transaction, which was initially announced on 19 February 2026, marks a significant milestone in the Company’s strategic objectives to expand its medical and healthcare service offerings.

The Company reported that all the conditions precedent stipulated in the Sale and Purchase Agreement (SPA) have either been met or duly waived. The acquisition was formally completed on 4 March 2026. As a direct result, PMG now holds 100% of the issued shares of Wellington Pte. Ltd., making Wellington an indirect subsidiary of Livingstone Health Holdings Limited.

Potential Impact on Shareholders and Share Price

• Strategic Expansion: The addition of Wellington Pte. Ltd. to the Group is expected to enhance Livingstone Health’s portfolio, positioning the Company for further growth and potentially increasing its market share in the healthcare sector.
• Value Creation: Shareholders should note that such strategic acquisitions often lead to synergies within operational activities, possibly resulting in improved financial performance and future earnings growth.
• Price Sensitivity: This acquisition represents a material development for the Company and could impact investor sentiment and share price, given its implications for future growth and expansion.
• Regulatory Note: The announcement has been reviewed by the Company’s sponsor, SAC Capital Private Limited, but not by the Singapore Exchange Securities Trading Limited (“SGX-ST”). The SGX-ST assumes no responsibility for the contents of the announcement.

Important Information for Shareholders

Shareholders are advised to monitor further updates from the Company regarding the integration of Wellington Pte. Ltd. into the Group as well as any disclosure of financial details or forward-looking statements that might be released in future announcements.

The acquisition may have a positive impact on the Company’s future performance, and as such, investors should consider this development in their investment decisions.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors are advised to conduct their own due diligence and consult their professional advisors before making any investment decisions. The Singapore Exchange Securities Trading Limited assumes no responsibility for the contents of this article.

View Livingstone Historical chart here